Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Heart Failure Devices: Raising Roadblocks To Readmission

Executive Summary

A new Medicare cost-control program aimed at reducing costly hospital readmissions has heart failure squarely in the cross-hairs, and the consequences could mean hundreds of thousands of dollars in lost Medicare revenue for hospitals that fail to meet the new readmission standards. As a result, providers are scrambling to implement programs to assess and reduce heart failure readmissions, and a growing number of device companies are touting a variety of technologies they believe could help them achieve that goal.

Advertisement

Related Content

Heart Failure: Next-Gen VADs Fuel Optimism Amid Challenges
ESC 2014 Shines Spotlight On The Future Of Cardiology
Digital Health Pushing Telemedicine To Center Stage
Abiomed Touts Advantages Of New Symphony Partial-Support Cardiac Assist Device
CardioMEMS’ Heart Failure Monitor Foiled At Panel By FDA Inspection Findings Of Study Bias
New CMS Hospital Readmissions, Efficiency Policies Make Device Companies Nervous
Cardiac Rhythm Management Market Faces Continued Challenges Ahead
Wireless and Mobile Monitoring: Bringing Health Care Home
Thoratec-HeartWare LVAD Deal Is Dead Following FTC Challenge
Cardiac Assist: Pumping up the Heart Failure Market

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT035481

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel